COMMUNIQUÉS West-GlobeNewswire

-
Passage Bio Announces New Dedicated Gene Therapy Manufacturing Suite
10/07/2019 -
Multiple Abstracts Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) to be Presented at the American Headache Society’s 61st Annual Scientific Meeting
10/07/2019 -
ORYZON to Present Data From ETHERAL Phase IIa Trial at the 2019 Alzheimer's Association International Conference in Los Angeles
10/07/2019 -
IntelGenx to Present at 12th Edition of Clinical Trials on Alzheimer’s Disease
10/07/2019 -
XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board
10/07/2019 -
GBT and Advocates Launch Disease Awareness Campaign Focused on Breaking Down Stigmas Associated with Sickle Cell Disease
10/07/2019 -
Axiom Real-Time Metrics Exhibiting at Outsourcing in Clinical Trials Medical Device Conference in Irvine, CA
10/07/2019 -
SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence
10/07/2019 -
aTyr Pharma to Host Key Opinion Leader Call and Webcast on Sarcoidosis and the Current Treatment Landscape
10/07/2019 -
ProMIS Neurosciences to Present Data at 2019 Alzheimer’s Association International Conference
10/07/2019 -
Orchestra BioMed™ Completes $34 Million Financing to Accelerate Product Pipeline Development and Advance Partnerships
10/07/2019 -
Medtronic Announces the Early Results of its Cash Tender Offers for up to $5.525 billion of Certain Outstanding Debt Securities Issued by Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A.
10/07/2019 -
Emerald Health Therapeutics Expands Distribution of its SYNC 25 CBD Oil to Two More Canadian Provinces
10/07/2019 -
Philips and Centre Hospitalier Régional Universitaire de Nancy announce 10-year enterprise informatics agreement to increase efficiency and improve patient care
10/07/2019 -
CROSSJECT annonce l'émission et l'attribution gratuite de BSA aux actionnaires
10/07/2019 -
Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma
10/07/2019 -
Sanofi : La FDA va examiner la demande d’approbation de l’isatuximab dans le traitement potentiel du myélome multiple réfractaire ou en rechute
10/07/2019 -
HealthEquity Announces Pricing of Public Offering of Common Stock
10/07/2019 -
Blissco Cannabis Corp. Announces 99.28% Shareholder Approval of Arrangement with The Supreme Cannabis Company, Inc.
10/07/2019
Pages